Earnings Alerts

Formosa Plastics (1301) Earnings: December Sales Surge by 9.42% to NT$16.45 Billion

By January 10, 2025 No Comments
  • Formosa Plastics reported sales of NT$16.45 billion in December.
  • Sales increased by 9.42% compared to previous figures.
  • There are currently mixed stock recommendations for Formosa Plastics: 2 analysts recommend buying, 9 recommend holding, and 1 recommends selling.

A look at Formosa Plastics Smart Scores

FactorScoreMagnitude
Value5
Dividend3
Growth3
Resilience3
Momentum2
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Formosa Plastics Corporation is positioned for a promising long-term outlook, as indicated by the Smartkarma Smart Scores. With a top score in Value, the company is deemed to offer strong value potential for investors. Additionally, it scores moderately in Dividend, Growth, Resilience, and Momentum, reflecting a well-rounded performance across these key factors. Formosa Plastics‘ core business of manufacturing and marketing plastics materials and chemical fiber products, including PVC resins, acrylic fiber, and caustic soda, provides a solid foundation for sustained growth and profitability in the future.

Overall, Formosa Plastics demonstrates a balanced outlook with strengths in value and a solid product portfolio spanning various chemical products. While showing potential for growth and maintaining resilience, the company’s momentum score reveals aspects that could be further optimized. Investors looking for a company with a strong value proposition in the plastics and chemical fiber industry may find Formosa Plastics an attractive investment opportunity based on the Smartkarma Smart Scores assessment.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars